Cargando…
Costs vs benefits of tackling COVID-19
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196038/ https://www.ncbi.nlm.nih.gov/pubmed/32382246 http://dx.doi.org/10.1007/s40274-020-6760-2 |
_version_ | 1783528643032514560 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7196038 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-71960382020-05-04 Costs vs benefits of tackling COVID-19 PharmacoEcon Outcomes News Comment Springer International Publishing 2020-05-02 2020 /pmc/articles/PMC7196038/ /pubmed/32382246 http://dx.doi.org/10.1007/s40274-020-6760-2 Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Comment Costs vs benefits of tackling COVID-19 |
title | Costs vs benefits of tackling COVID-19 |
title_full | Costs vs benefits of tackling COVID-19 |
title_fullStr | Costs vs benefits of tackling COVID-19 |
title_full_unstemmed | Costs vs benefits of tackling COVID-19 |
title_short | Costs vs benefits of tackling COVID-19 |
title_sort | costs vs benefits of tackling covid-19 |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196038/ https://www.ncbi.nlm.nih.gov/pubmed/32382246 http://dx.doi.org/10.1007/s40274-020-6760-2 |